These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6134063)

  • 41. Oxidative metabolism of peripheral blood neutrophils in chronic renal failure on conservative and dialysis treatment.
    Luciak M
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):93-5. PubMed ID: 1299177
    [No Abstract]   [Full Text] [Related]  

  • 42. Peripheral serotonergic system in hemodialyzed and peritoneally dialyzed patients.
    Malyszko J; Pawlak D; Malyszko J; Buczko W; Myśliwiec M
    Nephron; 2000 Nov; 86(3):396-7. PubMed ID: 11096322
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of latamoxef on platelet aggregation in hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients].
    Inoue T; Sakaguchi K; Yoshida K; Imai T; Kajimoto Y; Shirai D
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):177-83. PubMed ID: 3735768
    [No Abstract]   [Full Text] [Related]  

  • 44. III. Treatment modalities for ESRD patients.
    Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S51-62. PubMed ID: 10431002
    [No Abstract]   [Full Text] [Related]  

  • 45. Lipid abnormalities in end stage renal disease.
    Oda H; Keane WF
    Nephrol Dial Transplant; 1998; 13 Suppl 1():45-9. PubMed ID: 9507498
    [No Abstract]   [Full Text] [Related]  

  • 46. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alteration of pituitary-thyroid function in patients with chronic renal failure treated by haemodialysis or continuous ambulatory peritoneal dialysis.
    Ross RJ; Goodwin FJ; Houghton BJ; Boucher BJ
    Ann Clin Biochem; 1985 Mar; 22 ( Pt 2)():156-60. PubMed ID: 3923894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the correction of anemia with recombinant human erythropoietin on growth of children treated with CAPD.
    Stefanidis CJ; Koulieri A; Siapera D; Kapogiannis A; Mitsioni A; Michelis K
    Adv Perit Dial; 1992; 8():460-3. PubMed ID: 1361848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurotransmitter imbalance in plasma and cerebrospinal fluid during dialytic treatment.
    Biasioli S; Chiaramonte S; Fabris A; Feriani M; Pisani E; Ronco C; Valli A; Dalla Fior T; D'Andrea G; La Greca G
    Trans Am Soc Artif Intern Organs; 1983; 29():44-9. PubMed ID: 6143435
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparison of hemodialysis and continuous ambulatory peritoneal dialysis in children].
    Gagnadoux MF; Guest G
    Ann Pediatr (Paris); 1982 Nov; 29(9):627-9. PubMed ID: 7181408
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.
    Korbet SM
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):9-15. PubMed ID: 2648520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythropoietin dose requirement in a patient with HbH disease and renal failure.
    Winearls CG; Hughes RT; Pippard MJ; Cotes PM
    Nephrol Dial Transplant; 1992; 7(10):1052-4. PubMed ID: 1331884
    [No Abstract]   [Full Text] [Related]  

  • 54. Erythropoiesis in the anaemia of chronic renal failure: the response to CAPD.
    Coles GA; Cavill I
    Nephrol Dial Transplant; 1986; 1(3):170-4. PubMed ID: 3110671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in red cell mass, plasma volume and haematocrit in patients on continuous ambulatory peritoneal dialysis.
    de Paepe M; Lameire N; Schelstraete K; Ringoir S
    Proc Eur Dial Transplant Assoc; 1981; 18():286-9. PubMed ID: 7329973
    [No Abstract]   [Full Text] [Related]  

  • 56. [Problems in the treatment of the anemic syndrome in patients with chronic kidney failure].
    Dvoretskiĭ LI; Vorob'ev PA; Iaroslavtseva GN; Granich LP; Zaĭtsev SV
    Ter Arkh; 1986; 58(8):77-81. PubMed ID: 3764767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolism and kinetics of propylurofuranic acid in end-stage renal failure.
    Shinzato T; Morita H; Maeda K
    ASAIO J; 1994; 40(1):94-6. PubMed ID: 8186503
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pathogenesis and compensation of renal anemia in children].
    Müller-Wiefel DE
    Fortschr Med; 1982 Oct; 100(38):1765-8. PubMed ID: 6216194
    [No Abstract]   [Full Text] [Related]  

  • 59. [Acid resistance of the erythrocyte membranes in patients undergoing periodic hemodialysis treatment].
    Antonov S; Kiriakov Z; Vladimirova D; Kuleva V
    Vutr Boles; 1984; 23(3):49-53. PubMed ID: 6464432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemoglobin variability in dialysis patients.
    Brimble KS; Clase CM
    J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.